{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Cancer Drug Delivery Technologies

June 2, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.


BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Cancer Drug Delivery Technologies

June 2, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.


BioMedNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Phase 2 HARMONIC Trial Data Supporting LP-300 in EGFR-Mutant Lung Cancer

June 2, 2026Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, reported updated Phase 2 HARMONIC trial data showing that LP-300, in combination with carboplatin and pemetrexed, demonstrated a progression-free survival benefit that increased with treatment duration in patients with EGFR Exon 21 L858R-mutant non-small cell lung cancer who had progressed following TKI therapy. The emerging data showed a median progression-free survival of 8.


FinTechs on Notice as Digital Fraud Ticks Upwards

June 2, 2026The rapid shift of financial services into digital spaces is creating new opportunities for cybercriminals, many of whom are increasingly relying on AI to outsmart security checks. From fabricated identities to altered documents, fraudsters are using advanced tools to bypass verification systems that many financial technology companies still struggle to secure.


Renewable Energy Could Ease Food Production

June 2, 2026The disruption of global oil supplies following the Strait of Hormuz closure has pushed energy costs higher across every sector, including food. Modern food systems consume up to 30% of global oil supplies, making the fossil fuel integral to the agricultural sector.


Rallying Chip Stocks Reignite AI Bubble Debate

June 2, 2026Companies making AI chips have registered a major rally in the prices of their shares, and this has added momentum to the growing debates about whether or not these surges are fueling an AI bubble that could burst anytime. How long will this demand continue?


Rallying Chip Stocks Reignite AI Bubble Debate

June 2, 2026Companies making AI chips have registered a major rally in the prices of their shares, and this has added momentum to the growing debates about whether or not these surges are fueling an AI bubble that could burst anytime. How long will this demand continue?


Industrial Demand is Reshaping the Silver Market

June 2, 2026Silver has traditionally been viewed alongside gold as a safe-haven asset, attracting investors during inflationary periods and economic uncertainty. Today, however, the market is increasingly being driven by industrial consumption rather than investment demand alone.